- Home
- DHT vs AORT Comparison
DHT vs AORT Comparison
Compare DHT & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DHT | AORT |
|---|---|---|
| Founded | 2005 | 1984 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.1B |
| IPO Year | 2005 | 1993 |
Fundamental Metrics
Financial Performance| Metric | DHT | AORT |
|---|---|---|
| Price | $12.50 | $45.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $15.67 | ★ $49.36 |
| AVG Volume (30 Days) | ★ 1.6M | 356.3K |
| Earning Date | 02-04-2026 | 11-06-2025 |
| Dividend Yield | ★ 7.64% | N/A |
| EPS Growth | ★ 23.62 | N/A |
| EPS | ★ 1.24 | N/A |
| Revenue | ★ $538,571,000.00 | $422,646,000.00 |
| Revenue This Year | N/A | $15.97 |
| Revenue Next Year | $41.15 | $10.96 |
| P/E Ratio | $10.03 | ★ N/A |
| Revenue Growth | N/A | ★ 9.81 |
| 52 Week Low | $8.67 | $21.97 |
| 52 Week High | $13.85 | $48.04 |
Technical Indicators
Market Signals| Indicator | DHT | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 40.04 | 52.88 |
| Support Level | $12.27 | $42.68 |
| Resistance Level | $12.71 | $46.43 |
| Average True Range (ATR) | 0.26 | 1.31 |
| MACD | -0.09 | -0.11 |
| Stochastic Oscillator | 23.83 | 60.06 |
Price Performance
Historical ComparisonAbout DHT DHT Holdings Inc.
DHT Holdings Inc is a crude oil tanker company. Its fleet trades internationally and consists of crude oil tankers in the VLCC. The group generates revenues from time charter and spot market operations. It operates through integrated management companies in Monaco, Norway, Singapore, and India. The company generates the majority of its revenue from the shipping revenues.
About AORT Artivion Inc.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.